These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9448137)

  • 1. A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimus.
    Peterson LB; Cryan JG; Rosa R; Martin MM; Wilusz MB; Sinclair PJ; Wong F; Parsons JN; O'Keefe SJ; Parsons WH; Wyvratt M; Sigal NH; Williamson AR; Wiederrecht GJ
    Transplantation; 1998 Jan; 65(1):10-8. PubMed ID: 9448137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tacrolimus-related immunosuppressant with reduced toxicity.
    Dumont FJ; Koprak S; Staruch MJ; Talento A; Koo G; DaSilva C; Sinclair PJ; Wong F; Woods J; Barker J; Pivnichny J; Singer I; Sigal NH; Williamson AR; Parsons WH; Wyvratt M
    Transplantation; 1998 Jan; 65(1):18-26. PubMed ID: 9448138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only in the presence of immunophilins can cyclosporin and FK506 disrupt in vivo binding of calcineurin A to its autoinhibitory domain yet strengthen interaction between calcineurin A and B subunits.
    Chaudhuri B; Stephan C
    Biochem Biophys Res Commun; 1995 Oct; 215(2):781-90. PubMed ID: 7488022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex of FK506-binding protein 12 and FK506 inhibits calcineurin phosphatase activity and IgE activation-induced cytokine transcripts, but not exocytosis, in mouse mast cells.
    Fruman DA; Bierer BE; Benes JE; Burakoff SJ; Austen KF; Katz HR
    J Immunol; 1995 Feb; 154(4):1846-51. PubMed ID: 7530743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive and slow-binding inhibition of calcineurin by drug x immunophilin complexes.
    Salowe SP; Hermes JD
    Arch Biochem Biophys; 1998 Jul; 355(2):165-74. PubMed ID: 9675023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in
    Ianiri G; Applen Clancey S; Lee SC; Heitman J
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAP48, a new protein that forms specific complexes with both immunophilins FKBP59 and FKBP12. Prevention by the immunosuppressant drugs FK506 and rapamycin.
    Chambraud B; Radanyi C; Camonis JH; Shazand K; Rajkowski K; Baulieu EE
    J Biol Chem; 1996 Dec; 271(51):32923-9. PubMed ID: 8955134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein.
    Odom A; Del Poeta M; Perfect J; Heitman J
    Antimicrob Agents Chemother; 1997 Jan; 41(1):156-61. PubMed ID: 8980772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of a rapamycin-based high affinity binding FKBP12 ligand.
    Chakraborty TK; Weber HP; Nicolaou KC
    Chem Biol; 1995 Mar; 2(3):157-61. PubMed ID: 9383417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FK506, an immunosuppressant targeting calcineurin function.
    Dumont FJ
    Curr Med Chem; 2000 Jul; 7(7):731-48. PubMed ID: 10702636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity profiles of macrolactam immunosuppressant FK-506 analogues.
    Kawai M; Lane BC; Hsieh GC; Mollison KW; Carter GW; Luly JR
    FEBS Lett; 1993 Jan; 316(2):107-13. PubMed ID: 7678400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional structure and actions of immunosuppressants and their immunophilins.
    Braun W; Kallen J; Mikol V; Walkinshaw MD; Wüthrich K
    FASEB J; 1995 Jan; 9(1):63-72. PubMed ID: 7529736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of less nephrotoxic FK506 analogs and determining immunophilin dependence of immunosuppressant nephrotoxicity with a novel single-dose rat cisplatin potentiation assay.
    Mollison KW; Fey TA; Krause RA; Andrews JM; Bretheim PT; Brandt JA; Kawai M; Wagner R; Hsieh GC; Luly JR
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1509-19. PubMed ID: 9400028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus).
    Itoh S; Navia MA
    Protein Sci; 1995 Nov; 4(11):2261-8. PubMed ID: 8563622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of tacrolimus(FK506) and its metabolites with FKBP and calcineurin.
    Tamura K; Fujimura T; Iwasaki K; Sakuma S; Fujitsu T; Nakamura K; Shimomura K; Kuno T; Tanaka C; Kobayashi M
    Biochem Biophys Res Commun; 1994 Jul; 202(1):437-43. PubMed ID: 7518678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 32-Ascomycinyloxyacetic acid derived immunosuppressants. Independence of immunophilin binding and immunosuppressive potency.
    Wagner R; Rhoades TA; Or YS; Lane BC; Hsieh G; Mollison KW; Luly JR
    J Med Chem; 1998 May; 41(11):1764-76. PubMed ID: 9599228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the interaction between FK506 and FKBP12: a mechanism for formation of the calcineurin inhibitory complex.
    Ivery MT; Weiler L
    Bioorg Med Chem; 1997 Feb; 5(2):217-32. PubMed ID: 9061187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered analogs of ascomycin for nerve regeneration.
    Revill WP; Voda J; Reeves CR; Chung L; Schirmer A; Ashley G; Carney JR; Fardis M; Carreras CW; Zhou Y; Feng L; Tucker E; Robinson D; Gold BG
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1278-85. PubMed ID: 12183690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three distinct messenger RNAs can encode the human immunosuppressant-binding protein FKBP12.
    Peattie DA; Hsiao K; Benasutti M; Lippke JA
    Gene; 1994 Dec; 150(2):251-7. PubMed ID: 7529739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
    Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
    Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.